Sedating Drug “Operating Machinery” Warnings Need Clarification – FDAer
This article was originally published in The Tan Sheet
Executive Summary
Label statements advising "use caution when operating machinery" do not adequately communicate the risks consumers face from potentially sedating or impairing drugs, an FDA rep said Nov. 15
You may also be interested in...
Allegra Marketing Strategy “Drives On” In Response To Claritin Switch
Aventis will not change its marketing strategy for Allegra following the Rx-to-OTC switch of Schering-Plough's Claritin
Allegra Marketing Strategy “Drives On” In Response To Claritin Switch
Aventis will not change its marketing strategy for Allegra following the Rx-to-OTC switch of Schering-Plough's Claritin
Allegra Marketing Strategy “Drives On” In Response To Claritin Switch
Aventis will not change its marketing strategy for Allegra following the Rx-to-OTC switch of Schering-Plough's Claritin